ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored

October 24, 1997

More Bad News for AVEO As Tivozanib Partner Bids Adieu

May 31, 2013

NCAB Hung Up On removing $ 45 Million Limit For Core Grants

September 17, 1976

In Brief: NCAB Vacancies Remained Unfilled; AHF’s 20thAnniversary To Be Celebrated In NY May 24

May 5, 1989

Funding opportunities listed.

February 6, 2004

Slamon, Sherr Win Landon-AACR Prizes

March 7, 2003